Aesthetic Engg. NSE SME IPO review (Apply)

Review By Dilip Davda on August 6, 2024 •    The company is engaged in the business of building facades, aluminium doors/windows, GRC related contracts/services. •    It marked growth in its top lines for the last two fiscals. •    For FY24, it posted higher margins with value added contracts. •    With super…

Read More

Ashapura Logi NSE SME IPO review (Apply)

Review By Dilip Davda on July 26, 2024 •    ALL is an integrated logistics company in India providing all related services. •    Though it posted degrowth in top lines, bottom lines improved for the reported periods. •    It has created a niche place in the segment with many blue-chip clients. •  …

Read More

Akums Drugs IPO review (Apply)

Review By Dilip Davda on July 26, 2024 •    ADPL is a global player in CDMO and other pharma products with prime focus on India.  •    Its domestic market shares increased from 26.7% (FY21) to 30.2% (FY24). •    Due to provisioning of Put Option calls from EBITDA, it posted poor bottom lines…

Read More

S A Tech NSE SME IPO review (May apply)

  Review By Dilip Davda on July 24, 2024 •    It is an AI-driven IT consulting company having association with US based company. •    Based on its financial performance till FY23, it fared averagely. •    Based on FY25 super annualized earnings, the issue appears lucratively priced. •    Well-informed investors may park…

Read More

Chetana Education NSE SME IPO review (May apply)

Review By Dilip Davda on July 19, 2024 •    The company is engaged in educational book publishing and educational software. •    It posted growth in its top and bottom lines for the reported periods.  •    It is operating in a highly competitive and fragmented segment. •    Based on FY24 super earnings,…

Read More

Sati Poly NSE SME IPO review (May apply)

Review By Dilip Davda on July 10, 2024 •    The company is operating in a highly competitive and fragmented segment of flexi packaging business.  •    It posted almost static top lines for the last three fiscals with varying bottom lines. •    Based on FY24 super earnings, the issue appears aggressively priced.  •…

Read More